Scientists discovered that certain cancer cells use a low-level activation of a DNA-dismantling enzyme—normally seen in cell death—to survive treatment. Instead of dying, these “persister cells” ...
The emergence of cancer drug resistance remains one of the most pressing problems in cancer care and there is a critical need to devise approaches to mitigate it. However, the molecular mechanisms ...
Therapies that target the utilization of fat by tumors and activate a type of cell death dependent on fat molecules may be a ...
La Trobe researchers have made a discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and ...
The aim of immunotherapy strategies is to leverage cells in the patient's own immune system to destroy tumor cells. Using a preclinical model, scientists from the Institut Pasteur and Inserm ...
A protein involved with cell death can be manipulated to slow or reverse tumor growth, a pair of new studies in mice found. A colorized three dimensional micrographic scan of a melanoma cell. Recent ...